M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer Interventions: Drug: M7824; Drug: Placebo; Drug: Durvalumab; Drug: Etoposide; Drug: Pemetrexed; Drug: Carboplatin; Drug: Paclitaxel; Drug: Cisplatin; Radiation: Intensity Modulated Radiation Therapy (IMRT) Sponsors: EMD Serono Research & Development Institute, Inc.; Merck KGaA, Darmstadt, Germany Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials